UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Classical Complement Pathway in Experimental Autoimmune Myasthenia Gravis Pathogenesis

Annals of the New York Academy of Sciences, 2008-06, Vol.1132 (1), p.210-219

2008

Volltextzugriff (PDF)

A New Mouse Model of Autoimmune Ocular Myasthenia Gravis

Investigative ophthalmology & visual science, 2007-11, Vol.48 (11), p.5101-5111

2007

Volltextzugriff (PDF)

Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice

Immunology letters, 2015-12, Vol.168 (2), p.306-312

2015

Volltextzugriff (PDF)

CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

Journal of neuroimmunology, 2012-08, Vol.249 (1), p.1-7

2012

Volltextzugriff (PDF)

Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides

Anticancer research, 2011-11, Vol.31 (11), p.3683-3690

2011

Volltextzugriff (PDF)

Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization

Muscle & nerve, 2012-02, Vol.45 (2), p.209-216

2012

Volltextzugriff (PDF)

Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis

Cellular immunology, 2011, Vol.271 (2), p.292-298

2011

Volltextzugriff (PDF)

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2011-05, Vol.234 (1), p.165-167

2011

Volltextzugriff (PDF)

Pros and cons of treating murine myasthenia gravis with anti-C1q antibody

Journal of neuroimmunology, 2007-01, Vol.182 (1), p.167-176

2007

Volltextzugriff (PDF)

Targeting classical complement pathway to treat complement mediated autoimmune diseases

Advances in experimental medicine and biology, 2008-01, Vol.632, p.265

2008

Volltextzugriff (PDF)

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis

Journal of neuroimmunology, 2006-12, Vol.181 (1), p.29-33

2006

Volltextzugriff (PDF)

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

Journal of neuroimmunology, 2009-03, Vol.208 (1), p.40-45

2009

Volltextzugriff (PDF)

Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-02, Vol.194 (1), p.44-53

2008

Volltextzugriff (PDF)

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-05, Vol.196 (1), p.101-106

2008

Volltextzugriff (PDF)

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

Neuromuscular disorders : NMD, 2006-02, Vol.16 (2), p.137-143

2006

Volltextzugriff (PDF)

The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit

Journal of neuroimmunology, 2005-12, Vol.169 (1), p.177-179

2005

Volltextzugriff (PDF)

The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase

Inflammation, 2003-04, Vol.27 (2), p.79

2003

Volltextzugriff (PDF)

Multiple Tyrosine Protein Kinases in Rat Hippocampal Neurons: Isolation of Ptk-3, a Receptor Expressed in Proliferative Zones of the Developing Brain

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (5), p.1819-1823

1994

Volltextzugriff (PDF)

Ocular myasthenia gravis induced by human acetylcholine receptor subunit immunization in HLA DR3 transgenic mice

Immunology letters, 2015-12, Vol.168 (2), p.306-312

2015

Volltextzugriff (PDF)

Frequency of acetylcholine receptor specific B cells correlates with experimental myasthenia gravis severity (137.5)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.137-137.5

2009

Volltextzugriff (PDF)

Melittin Binds to Secretory Phospholipase A2and Inhibits Its Enzymatic Activity

Biochemical and biophysical research communications, 1997-09, Vol.238 (2), p.436-442

1997

Volltextzugriff (PDF)

CD4+ T cell independent LPS induced experimental autoimmune myasthenia gravis (EAMG)

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

Genetic evidence for the involvement of Fcγ receptor III in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2006-05, Vol.174 (1), p.157-167

2006

Volltextzugriff (PDF)

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-02, Vol.194 (1-2), p.44-53

2008

Volltextzugriff (PDF)

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2006-05, Vol.174 (1-2), p.157

2006

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Classical Complement Pathway in Experimental Autoimmune Myasthenia Gravis Pathogenesis

A New Mouse Model of Autoimmune Ocular Myasthenia Gravis

Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice

CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides

Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization

Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

Pros and cons of treating murine myasthenia gravis with anti-C1q antibody

Targeting classical complement pathway to treat complement mediated autoimmune diseases

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit

The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase

Multiple Tyrosine Protein Kinases in Rat Hippocampal Neurons: Isolation of Ptk-3, a Receptor Expressed in Proliferative Zones of the Developing Brain

Ocular myasthenia gravis induced by human acetylcholine receptor subunit immunization in HLA DR3 transgenic mice

Frequency of acetylcholine receptor specific B cells correlates with experimental myasthenia gravis severity (137.5)

Melittin Binds to Secretory Phospholipase A2and Inhibits Its Enzymatic Activity

CD4+ T cell independent LPS induced experimental autoimmune myasthenia gravis (EAMG)

Genetic evidence for the involvement of Fcγ receptor III in experimental autoimmune myasthenia gravis pathogenesis

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

Suchergebnisse filtern